Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2013. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by 3 franchises: neurology, endocrinology and urology-oncology. Moreover, the Group has an active policy of partnerships. Ipsen’s R&D is focused on its innovative and differentiated technological platforms, peptides and toxins. In 2013, R&D expenditure totaled close to €260 million, representing more than 21% of Group sales. Moreover, Ipsen also has a significant presence in primary care. The Group has close to 4,600 employees worldwide.
Contact details
Ipsen Mexico S. de R.L. de C.V.
Av. Presidente Mazaryk 29 – Piso 9
Col. Chapultepec Morales, Del. Miguel Hidalgo
CP 11570 Mexico DF
MEXICO
Tel: +52 (55) 3640 2100
Website: http://www.ipsen.com/
Mauricio Guizar, newly appointed general manager of Ipsen Mexico since October 2019, shares his first impression of the French specialty care player’s operations in Mexico, the significance of being the…
Mexico is a key market for Ipsen to consolidate its footprint in the Americas. The recently appointed general manager and the medical director of the Mexican affiliate discuss how penetrating…
At Valeant each region has a unique mix of prescription brands, branded generics and OTC products. The general manager for Mexico, Central America, the Caribbean and the Andean region discusses…
Providing logistics to the healthcare industry is part of Bomi’s DNA. The CEO of the Mexican affiliate shares his views about the changing Mexican distribution landscape, the company’s current activities…
Andres Matesanz, general manager of ChemSwiss Mexico, shares his views on the Mexican API industry and its regulations as well as his personal ambitions for the company’s future. You…
Siemens is the only company that covers the entire spectrum of diagnostics. The vice president of the healthcare division for Mesoamerica discusses the recent challenges the Mexican market has posed…
At Leo Pharma it’s not just about skin conditions. It’s about the people living with them. The recently appointed senior director for Latin America discusses the plans of the company…
Mayoly Spindler wants to be an international reference in gastroenterology. The general manger of the Mexican affiliate discusses how Mexico is contributing to this goal by always being one step…
As in human health, innovation is key in the animal health industry. The CEO and second generation at the head of Tornel presents the company’s most important milestones since its establishment…
World Courier is the most trusted specialty logistics company in the world for clinical trials. The general manager of the Mexico affiliate discusses the challenges clients face in the country…
The president of the Mexican Society of Cardiology sat down with us to share his view of the cardiology medical field in the country, why Mexico needs to collaborate more…
Novartis strives for “creating solutions for patients that go beyond the pill”. The country head and next president of CANIFARMA discusses how the company is using new programs and technology…
Considered one of the leading medical authorities in the country, David Kershenobich provides an overview about the new challenges faced by the Mexican healthcare system with the transition from infectious…
Thanks to the recognition COFEPRIS received from the Pan-American Health Organization as national regulatory authority of regional reference, Mexican manufacturers are increasingly eyeing foreign markets to grow. The general manager…
See our Cookie Privacy Policy Here
